CS logo
small CS logo
Institut Curie - Centre de Lutte Contre le Cancer (CLCC) de Paris; Service d Oncologie Pediatrique

Paris, France
Cancer treatment center in Paris
26 Rue d'Ulm, 75005 Paris

About Institut Curie - Centre de Lutte Contre le Cancer (CLCC) de Paris; Service d Oncologie Pediatrique


"L’Institut Curie, acteur de référence de la lutte contre le cancer, associe un Centre de Recherche de renommée internationale et un Ensemble Hospitalier de pointe qui prend en charge tous les cancers, y compris les plus rares. Fondé en 1909 par Marie Curie, l’Institut Curie rassemble sur trois sites (Paris, Saint-Cloud, Orsay) plus de 3 300 chercheurs, médecins et soignants autour de trois missions : la recherche, les soins et la conservation et la transmission des savoirs. Fondation privée reconnue d’utilité publique habilitée à recevoir des dons et des legs, l’Institut Curie peut, grâce au soutien de ses donateurs, favoriser les découvertes et ainsi améliorer les traitements et la qualité de vie des malades."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Total Rows: 1

Clinical Trials at Institut Curie - Centre de Lutte Contre le Cancer (CLCC) de Paris; Service d Oncologie Pediatrique


During the past decade, Institut Curie - Centre de Lutte Contre le Cancer (CLCC) de Paris; Service d Oncologie Pediatrique conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100Started TrialsCompleted Trails202100.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Bevacizumab (Avastin) in Combination With Temozolomide (TMZ) and Radiotherapy in Paediatric and Adolescent Participants With High-Grade Glioma
2011-10-18
2020-01-29
Completed
124
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors
2021-09-14
2030-07-03
Recruiting
42

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 2Hoffmann-La Roche: 2

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Institut Curie - Centre de Lutte Contre le Cancer (CLCC) de Paris; Service d Oncologie Pediatrique


According to Clinical.Site data, the most researched conditions in "Institut Curie - Centre de Lutte Contre le Cancer (CLCC) de Paris; Service d Oncologie Pediatrique" are "ALK Fusion-positive Solid or CNS Tumors" (1 trials) and "High Grade Glioma" (1 trials). Many other conditions were trialed in "Institut Curie - Centre de Lutte Contre le Cancer (CLCC) de Paris; Service d Oncologie Pediatrique" in a lesser frequency.

Clinical Trials Intervention Types at Institut Curie - Centre de Lutte Contre le Cancer (CLCC) de Paris; Service d Oncologie Pediatrique


Most popular intervention types in "Institut Curie - Centre de Lutte Contre le Cancer (CLCC) de Paris; Service d Oncologie Pediatrique" are "Drug" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Alectinib" (1 trials), "Bevacizumab" (1 trials), "Radiotherapy" (1 trials) and "Temozolomide (TMZ)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Institut Curie - Centre de Lutte Contre le Cancer (CLCC) de Paris; Service d Oncologie Pediatrique


The vast majority of trials in "Institut Curie - Centre de Lutte Contre le Cancer (CLCC) de Paris; Service d Oncologie Pediatrique" are 2 trials for "All" genders.

Clinical Trials Status at Institut Curie - Centre de Lutte Contre le Cancer (CLCC) de Paris; Service d Oncologie Pediatrique


Currently, there are NaN active trials in "Institut Curie - Centre de Lutte Contre le Cancer (CLCC) de Paris; Service d Oncologie Pediatrique". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Institut Curie - Centre de Lutte Contre le Cancer (CLCC) de Paris; Service d Oncologie Pediatrique, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Institut Curie - Centre de Lutte Contre le Cancer (CLCC) de Paris; Service d Oncologie Pediatrique, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 2Phase 2: 2Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 1Completed: 1Recruiting: 1Recruiting: 1

Departments of Institut Curie - Centre de Lutte Contre le Cancer (CLCC) de Paris; Service d Oncologie Pediatrique


Institut Curie - Centre de Lutte Contre le Cancer (CLCC) de Paris; Service d Oncologie Pediatrique has several departments that took part in Clinical trials: "Centre Claudius Regaud" - 18 trials, "CRLC Val d'Aurelle Paul-Lamarque" - 38 trials, "Institut de Cancerologie de l'Ouest" - 5 trials, "Centre Jean Perrin Centre Regional de Lutte Contre Le Cancer D auvergne" - 4 trials, "Centre Val d'Aurelle" - 2 trials, "ICM; Medecine B3" - 2 trials, "Centre Val Aurelle Paul Lamarque; Medecine A1 A2" - 2 trials